Avior Wealth Management LLC Grows Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Avior Wealth Management LLC grew its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 38.2% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,824 shares of the company's stock after buying an additional 3,270 shares during the period. Avior Wealth Management LLC's holdings in Prestige Consumer Healthcare were worth $1,017,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Kestra Investment Management LLC purchased a new position in Prestige Consumer Healthcare in the 4th quarter worth approximately $27,000. CIBC Private Wealth Group LLC grew its stake in Prestige Consumer Healthcare by 48.9% in the 4th quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company's stock worth $34,000 after buying an additional 152 shares in the last quarter. Opal Wealth Advisors LLC purchased a new stake in shares of Prestige Consumer Healthcare in the 1st quarter valued at $38,000. Headlands Technologies LLC purchased a new stake in shares of Prestige Consumer Healthcare in the 4th quarter valued at $40,000. Finally, McIlrath & Eck LLC boosted its stake in shares of Prestige Consumer Healthcare by 19.1% in the 4th quarter. McIlrath & Eck LLC now owns 959 shares of the company's stock valued at $75,000 after purchasing an additional 154 shares in the last quarter. Hedge funds and other institutional investors own 99.95% of the company's stock.

Analysts Set New Price Targets

PBH has been the subject of a number of research reports. Wall Street Zen raised shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a research note on Saturday, May 17th. Royal Bank Of Canada raised shares of Prestige Consumer Healthcare to a "hold" rating in a research note on Thursday, May 8th. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $93.33.

Prestige Consumer Healthcare Trading Down 0.3%

Shares of PBH opened at $83.37 on Friday. The stock has a market capitalization of $4.12 billion, a P/E ratio of 19.43, a PEG ratio of 2.50 and a beta of 0.45. The company has a quick ratio of 2.82, a current ratio of 4.20 and a debt-to-equity ratio of 0.55. The firm has a fifty day simple moving average of $83.93 and a two-hundred day simple moving average of $82.51. Prestige Consumer Healthcare Inc. has a twelve month low of $64.94 and a twelve month high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The company reported $1.32 earnings per share for the quarter, beating the consensus estimate of $1.30 by $0.02. The business had revenue of $296.52 million during the quarter, compared to analysts' expectations of $289.36 million. Prestige Consumer Healthcare had a net margin of 18.86% and a return on equity of 12.87%. The firm's revenue for the quarter was up 7.0% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.02 EPS. On average, research analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

Want to see what other hedge funds are holding PBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.